Kisspeptin and KPV (Lysine-Proline-Valine) get grouped together here mainly because they round out our catalog's coverage — not because they share a research mechanism. Worth being upfront about that. They're studied for genuinely different reasons, and treating them as related would misrepresent both.

Kisspeptin

Kisspeptin (commonly studied as the Kisspeptin-10 fragment) is a neuropeptide that sits at the top of the hypothalamic-pituitary-gonadal (HPG) axis — the signaling cascade that governs reproductive hormone regulation. It acts as the primary upstream trigger for GnRH (gonadotropin-releasing hormone) release, making it central to research on puberty onset, fertility, and reproductive endocrinology more broadly. Much of the research interest here concerns exactly where kisspeptin sits in that signaling hierarchy and how upstream changes cascade through the rest of the reproductive axis.

KPV (Lysine-Proline-Valine)

KPV is a tripeptide fragment, structurally derived from the C-terminal end of α-MSH — which puts it in the same broad family as Melanotan 2 and PT-141 by origin, but its research applications go in a different direction entirely. KPV's research profile centers on anti-inflammatory pathway activity, notably in gut inflammation and inflammatory bowel research models, often studied independently of classical melanocortin receptor activation.

Why the distinction matters

If your research protocol calls for a reproductive-axis signaling compound, kisspeptin is the relevant peptide. If it calls for an anti-inflammatory research compound, KPV is the relevant one — the two aren't interchangeable or complementary in a research design the way, say, CJC-1295 and Ipamorelin are. We'd rather be precise about that than imply a connection that isn't there.

Sourcing

Both are available with third-party lab verification. As with any specialized compound, confirm the COA's lot number matches your vial before use.